REFERENCES
- Celli BR, MacNee W: Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23:932–946.
- Thorley AJ, Tetley TD: Pulmonary epithelium, cigarette smoke, and chronic obstructive pulmonary disease. Int J Chron Obstruct Pulm Dis. 2007;2: 409–428.
- Dai XM: American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med. 2002;165:277–304.
- Selman M, King TE, Pardo A:Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med. 2001;134:136–151.
- Rogan MP, Geraghty P, Greene CM, O’Neill SJ, Taggart CC, McElvaney NG:Antimicrobial proteins and polypeptides in pulmonary innate defence. Respir Res. 2006;7:29.
- Williams SE, Brown TI, Roghanian A, Sallenave JM: SLPI and elafin: one glove, many fingers. Clin Sci (Lond). 2006;110: 21–35.
- Roghanian A, Williams SE, Sheldrake TA, Brown TI, Oberheim K, Xing Z, Howie SE, Sallenave JM: The antimicrobial/elastase inhibitor elafin regulates lung dendritic cells and adaptive immunity. Am J Respir Cell Mol Biol. 2006;34:634–642.
- Helleday R, Segerstedt B, Forsberg B, Mudway I, Nordberg G, Bernard A, Blomberg A: Exploring the time dependence of serum Clara cell protein as a biomarker of pulmonary injury in humans. Chest. 2006;130:672–675.
- Betsuyaku T, Takeyabu K, Tanino M, Nishimura M: Role of secretory leukocyte protease inhibitor in the development of subclinical emphysema. Eur Respir J. 2002;19:1051–1057.
- Lapperre TS, Willems LN, Timens W, Rabe KF, Hiemstra PS, Postma DS, Sterk PJ: Small airways dysfunction and neutrophilic inflammation in bronchial biopsies and BAL in COPD. Chest. 2007;131:53–59.
- Gompertz S, Bayley DL, Hill SL, Stockley RA: Relationship between airway inflammation and the frequency of exacerbations in patients with smoking related COPD. Thorax. 2001;56:36–41.
- Bernard A, Marchandise FX, Depelchin S, Lauwerys R, Sibille Y: Clara cell protein in serum and bronchoalveolar lavage. Eur Respir J. 1992;5:1231–1238.
- Pilette C, Godding V, Kiss R, Delos M, Verbeken E, Decaestecker C, De Paepe K, Vaerman JP, Decramer M, Sibille Y: Reduced epithelial expression of secretory component in small airways correlates with airflow obstruction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;163:185–194.
- Braido F, Riccio AM, Guerra L, Gamalero C, Zolezzi A, Tarantini F, De Giovanni B, Folli C, Descalzi D, Canonica GW: Clara cell 16 protein in COPD sputum: a marker of small airways damage? Respir Med. 2007;101:2119–2124.
- Herr C, Beisswenger C, Hess C, Kandler K, Suttorp N, Welte T, Schroeder JM, Vogelmeier C: Suppression of pulmonary innate host defence in smokers. Thorax. 2009;64:144–149.
- Tsoumakidou M, Tzanakis N, Siafakas NM: Induced sputum in the investigation of airway inflammation of COPD. Respir Med. 2003;97:863–871.
- Demedts IK, Bracke KR, Van Pottelberge G, Testelmans D, Verleden GM, Vermassen FE, Joos GF, Brusselle GG: Accumulation of dendritic cells and increased CCL20 levels in the airways of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007;175:998–1005.
- Grumelli S, Corry DB, Song LZ, Song L, Green L, Huh J, Hacken J, Espada R, Bag R, Lewis DE, Kheradmand F: An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema. PLoS Med. 2004;1:e8.
- Selman M, Carrillo G, Estrada A, Mejia M, Becerril C, Cisneros J, Gaxiola M, Perez-Padilla R, Navarro C, Richards T, Dauber J, King TE Jr, Pardo A, Kaminski N: Accelerated variant of idiopathic pulmonary fibrosis: clinical behavior and gene expression pattern. PLoS ONE. 2007;2:e482.
- Beeh KM, Beier J, Kornmann O, Buhl R: Neutrophilic inflammation in induced sputum of patients with idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis. 2003;20:138–143.
- Ghosh SK, Gerken TA, Schneider KM, Feng Z, McCormick TS, Weinberg A: Quantification of human β-defensin-2 and -3 in body fluids: application for studies of innate immunity. Clin Chem. 2007;53:757–765.